Evaluation of the opsonic capacity of core lipopolysaccharide antiserum of equine origin against smooth Escherichia coli 0111:B4, using macrophage chemiluminescence.

This research paper investigated if horse-derived antiserum could increase the phagocytosis of gram-negative bacteria by horse macrophages, with a focus on the Escherichia coli strain 0111:B4. The study involved using varying serum preparations and dilutions to observe the impact on bacterial absorption and chemiluminescence, a measurement of immune cell activity.

Study Overview

• The authors of the study aimed to find out if an equine antiserum, particularly against core lipopolysaccharide (LPS), could enhance the phagocytosis or ingestion of smooth gram-negative (GN) bacteria by horse macrophages, a type of immune cell.
• The research was driven by the theory that enhancing the opsonic capacity, meaning improving the ability of a pathogen to be marked for ingestion and destruction by immune cells, could lead to better immune response against certain harmful bacteria.

Methodology

• Horses were divided into two groups: Group A consisted of five healthy adult horses that were immunized with a bacterin from the J-5 mutant of E. coli 0111:B4 and Salmonella minnesota R595. This was done to produce antibodies specific to core LPS.
• The control group, Group B, consisted of five horses that were given a saline solution instead of the bacterin.
• Researchers collected serum from the horses in each group at various stages and created four distinct pools from these samples. These pools represented sera at different stages of the study, such as before immunization and after the last immunization or saline injection.
• These serum pools were either heated or left unheated and prepared in three dilutions (1/50, 1/100, 1/500) to opsonize the E.coli. Opsonization involves preparing the bacteria for phagocytosis using various antibodies or sera.
• The opsonised bacteria were then put through an assay to measure the activity of the equine peritoneal macrophages using chemiluminescence. Chemiluminescence is the emission of light as a result of a chemical reaction, in this case, the activity of the immune cells.
• The peritoneal fluid was gathered from healthy horses, and macrophages were purified for the assay by adhering to borosilicate glass containers, also known as scintillation vials.

Testing and Evaluation

• To execute the tests, each type of serum and its dilution was added to triplicate vials containing a specific number of bacterial colony units of E. coli 0111:B4.
• Chemiluminescence caused by the reaction was then measured with a liquid scintillation counter, a device used to measure radiation. The counter was used in an out-of-coincidence mode to independently verify the amount of light emitted due to the reaction.
• Each serum dilution was tested in duplicate vials without bacteria to examine any nonspecific chemiluminescence caused by the serum alone, i.e., not due to the bacteria reaction. This would provide a baseline level of chemiluminescence for comparison.